ARMC
IBB icon

American Research & Management Company’s iShares Biotechnology ETF IBB Stock Holding History

American Research & Management Company’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$294K Hold
2,510
– – 0.08% 103
2022
Q2 		$295K Buy
2,510
+325
+15% +$38.6K 0.08% 111
2022
Q1 		$285K Hold
2,185
– – 0.06% 118
2021
Q4 		$333K Hold
2,185
– – 0.07% 114
2021
Q3 		$353K Hold
2,185
– – 0.08% 104
2021
Q2 		$358K Hold
2,185
– – 0.08% 108
2021
Q1 		$329K Sell
2,185
-145
-6% -$23K 0.08% 111
2020
Q4 		$353K Hold
2,330
– – 0.09% 109
2020
Q3 		$316K Hold
2,330
– – 0.09% 102
2020
Q2 		$318K Buy
+2,330
New +$297K 0.1% 100
2020
Q1 		– Sell
-2,360
Closed -$284K – 328
2019
Q4 		$284K Hold
2,360
– – 0.08% 112
2019
Q3 		$235K Sell
2,360
-45
-2% -$4.71K 0.07% 121
2019
Q2 		$262K Hold
2,405
– – 0.08% 121
2019
Q1 		$269K Sell
2,405
-390
-14% -$42.8K 0.08% 123
2018
Q4 		$270K Sell
2,795
-15
-0.5% -$1.59K 0.09% 114
2018
Q3 		$343K Hold
2,810
– – 0.1% 109
2018
Q2 		$309K Buy
2,810
+95
+3% +$10.2K 0.11% 103
2018
Q1 		$290K Sell
2,715
-105
-4% -$11.6K 0.1% 113
2017
Q4 		$301K Sell
2,820
-165
-6% -$17.6K 0.09% 108
2017
Q3 		$332K Hold
2,985
– – 0.11% 101
2017
Q2 		$309K Sell
2,985
-210
-7% -$20.7K 0.1% 100
2017
Q1 		$312K Sell
3,195
-2,625
-45% -$251K 0.11% 90
2016
Q4 		$515K Sell
5,820
-10,860
-65% -$988K 0.18% 81
2016
Q3 		$1.61M Sell
16,680
-615
-4% -$58.5K 0.59% 50
2016
Q2 		$1.48M Sell
17,295
-1,155
-6% -$104K 0.57% 49
2016
Q1 		$1.6M Buy
18,450
+300
+2% +$26.8K 0.67% 44
2015
Q4 		$2.05M Buy
18,150
+1,650
+10% +$179K 0.87% 37
2015
Q3 		$1.67M Buy
16,500
+3,120
+23% +$374K 0.73% 46
2015
Q2 		$1.65M Buy
13,380
+11,655
+676% +$1.4M 0.67% 49
2015
Q1 		$197K Buy
+1,725
New +$190K 0.08% 109

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

American Research & Management Company's IBB Position: Q3 2022 in Review

American Research & Management Company held its iShares Biotechnology ETF (IBB) position steady in Q3 2022 at 2,510 shares worth $294K. The position accounts for 0.08% of the portfolio, ranked #103.

American Research & Management Company first reported a position in IBB in Q1 2015 and has held it in 30 quarters since. The position peaked at $2.05M in Q4 2015. 830 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • American Research & Management Company held 2,510 shares of iShares Biotechnology ETF worth $294K as of Q3 2022.
  • American Research & Management Company left its iShares Biotechnology ETF share count unchanged in Q3 2022.
  • iShares Biotechnology ETF made up 0.08% of American Research & Management Company's portfolio in Q3 2022, its #103 holding.
  • American Research & Management Company first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 30 quarters since.
  • American Research & Management Company's iShares Biotechnology ETF position peaked at $2.05M in Q4 2015.
  • 830 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.